Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterium tuberculosis antigens are molecular components—primarily proteins, but also lipids and carbohydrates—expressed by the bacterium M. tuberculosis, the causative agent of tuberculosis (TB). These antigens are recognized by the host immune system and play critical roles in both pathogenesis and immune response, making them important targets for diagnostics, vaccine development, and therapeutic interventions. Key examples include the Antigen 85 Complex (Ag85A, Ag85B, Ag85C), PE-PGRS family proteins, PTRP, MtrA, and Lipoarabinomannan (LAM).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis Antigen(s).